Rate My Professor Tanja Mueller

Dr Tanja Mueller is Senior Lecturer in the Strathclyde Institute of Pharmacy and Biomedical Sciences at the University of Strathclyde. She completed a PhD at the University of Strathclyde in 2017 on the use of direct oral anticoagulants in Scotland, an MSc at Malmö University in 2014, an MPH at Lund University in 2014, and a BA at Europäische Fernhochschule Hamburg in 2011. She joined the University of Strathclyde in 2014 as a PhD student and has remained at the Strathclyde Institute of Pharmacy and Biomedical Sciences, progressing to her current position. Her research centres on the rational use of medicines, with a primary focus on pharmacoepidemiology, particularly drug utilisation studies, alongside health policy topics such as medicines used in cancer and cardiovascular disease, antimicrobial stewardship, drug adherence, treatment outcomes, and electronic record linkage. She applies statistical methods and mixed-methods approaches in her work. Mueller has undertaken secondments and honorary appointments at Public Health Scotland, including a secondment from 2021 to 2023 and an honorary appointment from 2023 onward, and has served as Visiting Lecturer in Pharmacoepidemiology and Health Services Research at NHS Lanarkshire since 2024. She is also Visiting Professor at the Federal University of Ouro Preto in Brazil. She teaches across all years of the MPharm programme, covering information gathering, research methods, and communication skills, as well as critical appraisal, research methods, study designs, data analysis, and statistics on the MSc Clinical Pharmacy course. She supervises undergraduate, taught postgraduate, and research postgraduate students. Her contributions include numerous publications, such as recent papers on the Scottish Medicines in Pregnancy programme, the UK Antimicrobial Registry, and the impact of COVID-19 on antidepressant use, along with roles as Associate Editor for Exploratory Research in Clinical and Social Pharmacy and multiple awards for reviewing excellence. She is a Fellow of the Royal Society for Public Health.

Mueller’s work has advanced understanding of real-world medicine use and health services, supporting surveillance programmes and policy development in Scotland and internationally. Her interdisciplinary approach bridges pharmaceutical sciences with public health and societal issues, fostering research skills among students and contributing to the broader academic field through editorial service and collaborative projects.